Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17431211 | 0.90 | ATM (0.45) | KDM4EATML3MBTL1MEN1POLB | |
| SCHEMBL17431174 | 0.89 | KDM4E (0.46) | KDM4EATML3MBTL1MEN1POLB | |
| SCHEMBL17431201 | 0.83 | MAPT (0.42) | KDM4EL3MBTL1MEN1POLBMAPT | |
| SCHEMBL16870091 | 0.79 | CA9 (0.36) | KDM4EATML3MBTL1MEN1POLB | |
| SCHEMBL10014626 | 0.78 | ATM (0.52) | KDM4EATML3MBTL1MEN1POLB | |
| SCHEMBL19830384 | 0.78 | KDM4E (0.31) | KDM4EATML3MBTL1 | |
| SCHEMBL19830777 | 0.78 | KDM4E (0.31) | KDM4EATML3MBTL1 | |
| SCHEMBL24936738 | 0.77 | BACE1 (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL17246522 | 0.77 | SMN1; SMN2 (0.35) | KDM4EATML3MBTL1MEN1MAPT | |
| SCHEMBL17246083 | 0.77 | KDM4E (0.53) | KDM4EATML3MBTL1MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160013422-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-01-14 | — | — | US | disclosed |
| US-20160013422-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160013422-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, NR4A3, OXSR1 | KDM4E 2233/4885ATM 4214/4885L3MBTL1 1627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.